Morgan Stanley’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,057,383
| Closed | -$89.8M | – | 6928 |
|
|
2019
Q4 | $89.8M | Buy |
1,057,383
+756,359
| +251% | +$50.4M | 0.02% | 651 |
|
|
2019
Q3 | $15.1M | Sell |
301,024
-31,209
| -9% | -$1.24M | ﹤0.01% | 1732 |
|
|
2019
Q2 | $12.1M | Buy |
332,233
+282,029
| +562% | +$9.21M | ﹤0.01% | 1954 |
|
|
2019
Q1 | $1.4M | Sell |
50,204
-66,016
| -57% | -$1.56M | ﹤0.01% | 3877 |
|
|
2018
Q4 | $2.23M | Sell |
116,220
-60,074
| -34% | -$1.4M | ﹤0.01% | 3679 |
|
|
2018
Q3 | $5.27M | Sell |
176,294
-3,820
| -2% | -$144K | ﹤0.01% | 3139 |
|
|
2018
Q2 | $6.61M | Sell |
180,114
-22,039
| -11% | -$716K | ﹤0.01% | 2833 |
|
|
2018
Q1 | $6.66M | Buy |
202,153
+19,997
| +11% | +$625K | ﹤0.01% | 2726 |
|
|
2017
Q4 | $4.98M | Buy |
182,156
+58,231
| +47% | +$1.79M | ﹤0.01% | 3111 |
|
|
2017
Q3 | $4.59M | Buy |
123,925
+9,551
| +8% | +$352K | ﹤0.01% | 3045 |
|
|
2017
Q2 | $4.35M | Sell |
114,374
-19,260
| -14% | -$858K | ﹤0.01% | 3004 |
|
|
2017
Q1 | $6.54M | Sell |
133,634
-85,877
| -39% | -$3.92M | ﹤0.01% | 2590 |
|
|
2016
Q4 | $7.45M | Buy |
219,511
+156,711
| +250% | +$5.56M | ﹤0.01% | 2572 |
|
|
2016
Q3 | $2.37M | Buy |
62,800
+31,362
| +100% | +$1.18M | ﹤0.01% | 3357 |
|
|
2016
Q2 | $1.06M | Buy |
31,438
+10,001
| +47% | +$353K | ﹤0.01% | 3931 |
|
|
2016
Q1 | $681K | Sell |
21,437
-56,475
| -72% | -$1.84M | ﹤0.01% | 4222 |
|
|
2015
Q4 | $2.91M | Sell |
77,912
-281,983
| -78% | -$10.7M | ﹤0.01% | 3171 |
|
|
2015
Q3 | $13.7M | Buy |
359,895
+109,002
| +43% | +$3.83M | 0.01% | 1689 |
|
|
2015
Q2 | $7.18M | Sell |
250,893
-930,727
| -79% | -$25.9M | ﹤0.01% | 2450 |
|
|
2015
Q1 | $33.1M | Buy |
1,181,620
+1,141,398
| +2,838% | +$32.1M | 0.01% | 1092 |
|
|
2014
Q4 | $1.11M | Sell |
40,222
-122,572
| -75% | -$3.04M | ﹤0.01% | 4068 |
|
|
2014
Q3 | $3.63M | Buy |
162,794
+92,686
| +132% | +$2.35M | ﹤0.01% | 2911 |
|
|
2014
Q2 | $2.04M | Sell |
70,108
-72,852
| -51% | -$1.95M | ﹤0.01% | 3467 |
|
|
2014
Q1 | $4.06M | Sell |
142,960
-65,852
| -32% | -$2.18M | ﹤0.01% | 2770 |
|
|
2013
Q4 | $8.06M | Buy |
208,812
+88,685
| +74% | +$3.17M | ﹤0.01% | 2122 |
|
|
2013
Q3 | $4.03M | Sell |
120,127
-70,769
| -37% | -$2.25M | ﹤0.01% | 2636 |
|
|
2013
Q2 | $5.87M | Buy |
+190,896
| New | +$6.39M | ﹤0.01% | 2172 |
|
Other funds holding MDCO
Morgan Stanley's MDCO Position: Q1 2020 in Review
Morgan Stanley sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 1,057,383 shares — an estimated $89.8M sold.
Morgan Stanley first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $89.8M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Morgan Stanley reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Morgan Stanley sold 1,057,383 Medicines Co shares in Q1 2020, an estimated $89.8M.
- Morgan Stanley first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
- Morgan Stanley's Medicines Co position peaked at $89.8M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Morgan Stanley's 13F filing for Q1 2020, filed 15 May 2020.